The management of fibromyalgia-associated syndromes (Q34746550)

4 August 2017

1 reference

title

The management of fibromyalgia-associated syndromes (English)

1 reference

4 August 2017

0 references

David S Silver

1

1 reference

4 August 2017

Daniel J Wallace

series ordinal

2

1 reference

4 August 2017

publication date

1 May 2002

1 reference

Rheumatic Diseases Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

28

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

405-417

1 reference

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Postinfectious fatigue: prospective cohort study in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Viral serologies in patients with chronic fatigue and chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Current terminology and diagnostic classification schemes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Identification of neck-shoulder disorders in a 1 year follow-up study. Validation Of a questionnaire-based method

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Prevalence and clinical outcome of mitral-valve prolapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Reflex sympathetic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Prevalence of fibromyalgia in systemic lupus erythematosus patients: comment on the article by Middleton et al.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

New concepts of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

The autonomic nervous system in functional bowel disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

The irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Is there an irritable bladder in the irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

The relationship between fibromyalgia and interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Interstitial cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Restless legs syndrome: a review of clinical and pathophysiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Sympathetic nervous system function in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

"Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Clinical and Immunomodulatory Effect of Fun-boi, an Herbal Medicine, in Rheumatoid Arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Prognostic factors for persons with idiopathic chronic fatigue.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Intravenous regional phenoxybenzamine in the treatment of reflex sympathetic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

Stress Management for Irritable Bowel Syndrome: A Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900003-0

7 January 2021

10.1016/S0889-857X(02)00003-0

Identifiers

DOI

1 reference

4 August 2017

1 reference